Guardant Health is a precision oncology company specializing in blood-based genomic profiling and liquid biopsy assays that detect circulating tumor DNA to guide cancer treatment, monitoring, and clinical trial enrollment. Guardant Health distinguishes itself through scalable, clinically validated tests and a large real-world genomic and clinical data platform that accelerates personalized therapy decisions and drug development.
EN